Next Article in Journal
Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose
Previous Article in Journal
The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses
 
 
Article

Article Versions Notes

Vaccines 2022, 10(8), 1300; https://doi.org/10.3390/vaccines10081300
Action Date Notes Link
article pdf uploaded. 11 August 2022 11:37 CEST Version of Record https://www.mdpi.com/2076-393X/10/8/1300/pdf-vor
article pdf uploaded. 11 August 2022 11:47 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1300/pdf-vor
article pdf uploaded. 11 August 2022 11:52 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1300/pdf-vor
article xml file uploaded 15 August 2022 10:19 CEST Original file -
article xml uploaded. 15 August 2022 10:19 CEST Update https://www.mdpi.com/2076-393X/10/8/1300/xml
article pdf uploaded. 15 August 2022 10:19 CEST Updated version of record https://www.mdpi.com/2076-393X/10/8/1300/pdf
article html file updated 15 August 2022 10:20 CEST Original file -
article html file updated 24 August 2022 21:00 CEST Update https://www.mdpi.com/2076-393X/10/8/1300/html
Back to TopTop